Cargando…
Treatment of Postsurgical Clinically Nonfunctioning Pituitary Adenomas Remnants With Cabergoline
Background: The standard first-line therapy for clinically nonfunctioning adenomas (NFPA) is transsphenoidal surgery, however there is no consensus of the optimal postsurgical treatment for residual adenoma. Medical therapy, such as cabergoline (CAB), may be an alternative for preventing growth of p...
Autores principales: | Vieira, Marina C M, Lima, José V, Scalco, Renata C, Scalissi, Nilza M, Bueno, Cristina B F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090741/ http://dx.doi.org/10.1210/jendso/bvab048.1075 |
Ejemplares similares
-
Immunohistochemical Profile of Nonfunctioning Pituitary Adenomas
por: Solovey, Mariana, et al.
Publicado: (2021) -
SAT-480 Clinical Cases TSH Secreting Adenomas
por: Calasans, Camila, et al.
Publicado: (2019) -
MON-424 Suprasellar Immature Cystic Teratoma: A Case Report
por: Franco, Pedro, et al.
Publicado: (2019) -
ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022) -
PMON170 Treating human primary non-functioning pituitary adenoma cells with cabergoline
por: Begalli, Federica, et al.
Publicado: (2022)